01 1CIPLA LIMITED Mumbai IN
02 1Cadila Healthcare Limited Ahmedabad IN
03 2DEBIOPHARM INTERNATIONAL S.A. Lausanne CH
04 1Desynth SA Ciudad Autonoma De Buenos Aires AR
05 1ERIOCHEM S.A. Colonia Avellaneda, Entre Rios AR
06 1FRESENIUS KABI ONCOLOGY LIMITED Kalyani IN
07 2HERAEUS PRECIOUS METALS GMBH & CO. KG Hanau DE
08 1HETERO LABS LIMITED Hyderabad IN
09 1HOSPIRA BOULDER, INC. Boulder US
10 1HUBEI HAOSUN PHARMACEUTICAL CO., LTD. Ezhou CN
11 2JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. Lianyungang CN
12 1KUNMING GUIYAN PHARMACEUTICAL CO., LTD. Kunming CN
13 1LAURUS LABS LIMITED Hyderabad IN
14 1LAURUS LABS PRIVATE LIMITED Hyderabad IN
15 1LIANYUNGANG JARI PHARMACEUTICAL CO., LTD. Lianyungang CN
16 1PLIVA - Lachema a.s. Brno CZ
17 1POLYMED THERAPEUTICS, INC. Houston US
18 1QILU PHARMACEUTICAL CO., LTD. Jinan CN
19 1SHANDONG BOYUAN PHARMACEUTICAL CO., LTD. Jinan City CN
20 1SHILPA PHARMA LIFESCIENCES LIMITED Raichur IN
21 1SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai IN
22 1TEVA PHARMACEUTICAL INDUSTRIES LTD Tel Aviv - Jaffa IL
23 2UMICORE ARGENTINA S.A. Pilar Industrial Park AR
24 1VUAB Pharma a.s. Roztoky CZ
25 1Zhejiang Hisun Pharmaceutical Co., Ltd. Taizhou City CN
01 24Oxaliplatin
02 1Oxaliplatin, LB
03 1Oxaliplatin, Process 2
04 1Oxaliplatin, Process HER-1
05 1Oxaliplatin, Process HER-2
06 1Oxaliplatin, Process II
01 2Argentina
02 8China
03 1Croatia
04 1Czech Republic
05 4Germany
06 8India
07 1Israel
08 2Switzerland
09 2U.S.A
01 2Expired
02 18Valid
03 1Withdrawn by EDQM Failure to CEP procedure
04 8Withdrawn by Holder
Certificate Number : R1-CEP 2007-296 - Rev 02
Status : Valid
Issue Date : 2019-07-26
Type : Chemical
Substance Number : 2017
Certificate Number : R1-CEP 2003-229 - Rev 05
Status : Valid
Issue Date : 2022-10-18
Type : Chemical
Substance Number : 2017
Certificate Number : R1-CEP 2007-130 - Rev 00
Status : Valid
Issue Date : 2014-07-30
Type : Chemical
Substance Number : 2017
Certificate Number : CEP 2003-278 - Rev 08
Status : Valid
Issue Date : 2023-10-02
Type : Chemical
Substance Number : 2017
Certificate Number : CEP 2006-137 - Rev 05
Status : Valid
Issue Date : 2023-10-02
Type : Chemical
Substance Number : 2017
Certificate Number : CEP 2015-112 - Rev 01
Status : Valid
Issue Date : 2024-10-14
Type : Chemical
Substance Number : 2017
Certificate Number : CEP 2005-079 - Rev 04
Status : Valid
Issue Date : 2024-07-30
Type : Chemical
Substance Number : 2017
Certificate Number : R1-CEP 2006-201 - Rev 02
Status : Valid
Issue Date : 2022-07-20
Type : Chemical
Substance Number : 2017
Certificate Number : R1-CEP 2005-259 - Rev 03
Status : Valid
Issue Date : 2021-11-22
Type : Chemical
Substance Number : 2017
Certificate Number : R1-CEP 2010-002 - Rev 03
Status : Valid
Issue Date : 2020-02-19
Type : Chemical
Substance Number : 2017
A Oxaliplatin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oxaliplatin, including repackagers and relabelers. The FDA regulates Oxaliplatin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oxaliplatin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Oxaliplatin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Oxaliplatin supplier is an individual or a company that provides Oxaliplatin active pharmaceutical ingredient (API) or Oxaliplatin finished formulations upon request. The Oxaliplatin suppliers may include Oxaliplatin API manufacturers, exporters, distributors and traders.
click here to find a list of Oxaliplatin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Oxaliplatin CEP of the European Pharmacopoeia monograph is often referred to as a Oxaliplatin Certificate of Suitability (COS). The purpose of a Oxaliplatin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Oxaliplatin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Oxaliplatin to their clients by showing that a Oxaliplatin CEP has been issued for it. The manufacturer submits a Oxaliplatin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Oxaliplatin CEP holder for the record. Additionally, the data presented in the Oxaliplatin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Oxaliplatin DMF.
A Oxaliplatin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Oxaliplatin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Oxaliplatin suppliers with CEP (COS) on PharmaCompass.
We have 24 companies offering Oxaliplatin
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?